IGIBi003-A

Registration Summary:

A P E C

SCA12_002

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	IGIBi003-A
Cite as:	IGIBi003-A (RRID:CVCL_VN64)
Alternative name(s)	SCA12_002
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	11th July 2022
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	CSIR-Institute of Genomics and Integrative Biology (IGIB)
External Databases
Cellosaurus	CVCL_VN64
Wikidata	Q94314642
General Information
Publications	Kumar D et al. Generation of three spinocerebellar ataxia type-12 patients derived induced pluripotent stem cell lines (IGIBi002-A, IGIBi003-A and IGIBi004-A). Stem cell research. 2018 Aug;31:216-221. Srivastava AchalK et al. Spinocerebellar ataxia type 12: An update. Annals of Movement Disorders. 2019-00-00. Bhargava N et al. Generation and characterization of induced pluripotent stem cell line (IGIBi001-A) from a sickle cell anemia patient with homozygous β-globin mutation. Stem cell research. 2019 Aug;39:101484. Slanzi A et al. In vitro Models of Neurodegenerative Diseases. Frontiers in cell and developmental biology. 2020;8:328. Tyagi Nishu et al. RNA toxicity in tandem nucleotide repeats mediated neurodegenerative disorders. Rna-Based Regulation in Human Health and Disease. 2020-00-00. Kumar M et al. Generation of induced pluripotent stem cell line (IGIBi007-A) from a patient with a novel acromesomelic dysplasia, PRKG2 type (AMDP). Stem cell research. 2021 May;53:102340. Hommersom MP et al. Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias. Stem cell reviews and reports. 2022 Feb;18(2):441-456. Tyagi Nishu et al. Investigation of RFC1 tandem nucleotide repeat locus in diverse neurodegenerative outcomes in an Indian cohort. neurogenetics. 2023-11-02. Zahra S et al. Generation of an Induced pluripotent stem cell (iPSC) line (IGIBi011-A) from a Spinocerebellar ataxia type 12 gait dominant patient. Stem cell research. 2024 Apr;76:103319. Kumar M et al. Molecular clues unveiling spinocerebellar ataxia type-12 pathogenesis. iScience. 2024 May 17;27(5):109768.

hIPSC Derivation

General